Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-25

Clinical Trial Update: Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women [NA]

View source ↗

Summary

A clinical trial is evaluating the efficacy of the alpha-blocker tamsulosin for symptomatic dysuria in women with multiple sclerosis. The study is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamsulosin (tamsulosin)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Multiple Sclerosis, Dysuria | NA | Status: RECRUITING